Time to antibiotics administration and outcome in community-acquired pneumonia: Secondary analysis of a randomized controlled trial - Marti, C.; John, G.; Genne, D.; Prendki, V.; Rutschmann, O. T.; Stirnemann, J.; Garin, N. (Eur J Intern Med, 2017)
BACKGROUND: The association between early antibiotic administration and outcomes remains controversial in patients hospitalized for community-acquired pneumonia. METHODS: We performed a secondary analysis of a randomized controlled trial comparing two antibiotic treatment strategies for patients hospitalized for moderately severe CAP. The univariate and multivariate associations between time to antibiotic administration (TTA) and time to clinical stability were assessed using a Cox proportional hazard model. Secondary outcomes were death, intensive care unit admission and hospital readmission up to 90days. RESULTS: 371 patients (mean age 76years, CURB-65 score>/=2 in 52%) were included. Mean TTA was 4.35h (SD 3.48), with 58.5% of patients receiving the first antibiotic dose within 4h. In multivariate analysis, number of symptoms and signs (HR 0.876, 95% CI 0.784-0.979, p=0.020), age (HR 0.986, 95% CI 0.975-0.996, p=0.007), initial heart rate (HR 0.992, 95% CI 0.986-0.999, p=0.023), and platelets count (HR 0.998, 95% CI 0.996-0.999, p=0.004) were associated with a reduced probability of reaching clinical stability. The association between TTA and time to clinical stability was not significant (HR 1.009, 95% CI 0.977-1.042, p=0.574). We found no association between TTA and the risk of intensive care unit admission, death or readmission up to 90days after the initial admission. CONCLUSION: In patients hospitalized for moderately severe CAP, a shorter time to antibiotic administration was not associated with a favorable outcome. These findings support the current recommendations that do not assign a specific time frame for antibiotics administration.
Keywords: journalArticle; *Time-to-Treatment; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents/*therapeutic use; Community-Acquired Infections/*drug therapy/mortality; Community-acquired pneumonia; Female; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Outcome; Patient Readmission/*statistics & numerical data; Pneumonia/*drug therapy/mortality; Proportional Hazards Models; Severity of Illness Index; Switzerland; Time to antibiotics; Young Adult